Seb Lamprecht

633 total citations
12 papers, 497 citations indexed

About

Seb Lamprecht is a scholar working on Hematology, Immunology and Surgery. According to data from OpenAlex, Seb Lamprecht has authored 12 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Immunology and 3 papers in Surgery. Recurrent topics in Seb Lamprecht's work include Platelet Disorders and Treatments (9 papers), Complement system in diseases (5 papers) and Blood groups and transfusion (4 papers). Seb Lamprecht is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Complement system in diseases (5 papers) and Blood groups and transfusion (4 papers). Seb Lamprecht collaborates with scholars based in Belgium, South Africa and United States. Seb Lamprecht's co-authors include Jan Roodt, Hans Deckmyn, Muriel Meiring, Walter J. Janse van Rensburg, Karen Vanhoorelbeke, Inge Pareyn, Nele Vandeputte, Alexandre Fontayne, S Vauterin and Josefin-Beate Holz and has published in prestigious journals such as Blood, Arteriosclerosis Thrombosis and Vascular Biology and Thrombosis and Haemostasis.

In The Last Decade

Seb Lamprecht

12 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Seb Lamprecht Belgium	9	321	250	108	101	91	12	497
Alexandra Schiviz Austria	12	396 1.2×	231 0.9×	91 0.8×	47 0.5×	97 1.1×	22	572
Magnus Mansouri Taleghani Switzerland	4	238 0.7×	377 1.5×	198 1.8×	22 0.2×	132 1.5×	7	491
Inge Scharrer Germany	6	239 0.7×	129 0.5×	76 0.7×	70 0.7×	72 0.8×	8	344
Spero Cataland Austria	1	203 0.6×	320 1.3×	165 1.5×	20 0.2×	107 1.2×	2	429
Koji Suzuki Japan	9	186 0.6×	77 0.3×	30 0.3×	55 0.5×	56 0.6×	11	343
Dominique Tersago United States	3	203 0.6×	329 1.3×	165 1.5×	20 0.2×	107 1.2×	6	440
Anne Schoolmeester Belgium	5	218 0.7×	73 0.3×	20 0.2×	90 0.9×	29 0.3×	5	325
Peter Meeus Belgium	11	122 0.4×	95 0.4×	15 0.1×	57 0.6×	169 1.9×	20	385
Henk Louwes Netherlands	8	358 1.1×	40 0.2×	49 0.5×	44 0.4×	87 1.0×	14	448
CW Jackson United States	14	444 1.4×	65 0.3×	32 0.3×	60 0.6×	87 1.0×	31	576

Countries citing papers authored by Seb Lamprecht

Since Specialization

Citations

This map shows the geographic impact of Seb Lamprecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seb Lamprecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seb Lamprecht more than expected).

Fields of papers citing papers by Seb Lamprecht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seb Lamprecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seb Lamprecht. The network helps show where Seb Lamprecht may publish in the future.

Co-authorship network of co-authors of Seb Lamprecht

This figure shows the co-authorship network connecting the top 25 collaborators of Seb Lamprecht. A scholar is included among the top collaborators of Seb Lamprecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seb Lamprecht. Seb Lamprecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Tersteeg, Claudia, Jan Roodt, Walter J. Janse van Rensburg, et al.. (2016). N-acetylcysteine in preclinical mouse and baboon models of thrombotic thrombocytopenic purpura. Blood. 129(8). 1030–1038. 47 indexed citations

Feys, Hendrik B., Jan Roodt, Nele Vandeputte, et al.. (2012). Inhibition of von Willebrand factor–platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons. Blood. 120(17). 3611–3614. 27 indexed citations

Callewaert, Filip, Jan Roodt, Hans Ulrichts, et al.. (2012). Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura. Blood. 120(17). 3603–3610. 106 indexed citations

Rensburg, Walter J. Janse van, Jan Roodt, Seb Lamprecht, Muriel Meiring, & P N Badenhorst. (2012). Tirofiban versus abciximab: tirofiban is administered at suboptimal dosages when evaluated in an arterial thrombosis model in non-human primates. Clinical and Experimental Medicine. 12(4). 257–263. 4 indexed citations

Feys, Hendrik B., Jan Roodt, Nele Vandeputte, et al.. (2010). Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus). Blood. 116(12). 2005–2010. 87 indexed citations

Fontayne, Alexandre, et al.. (2008). The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons. Thrombosis and Haemostasis. 100(10). 670–677. 54 indexed citations

Badenhorst, P N, Seb Lamprecht, Jan Roodt, et al.. (2007). Coronary artery in-stent stenosis persists despite inhibition of the von Willebrand factor - collagen interaction in baboons. Thrombosis and Haemostasis. 98(12). 1343–1349. 13 indexed citations

Fontayne, Alexandre, Karen Vanhoorelbeke, Inge Pareyn, et al.. (2006). Rational humanization of the powerful antithrombotic anti-GPIbalpha antibody: 6B4.. PubMed. 96(5). 671–84. 27 indexed citations

Fontayne, Alexandre, Karen Vanhoorelbeke, Inge Pareyn, et al.. (2006). Rational humanization of the powerful antithrombotic anti-GPIbα antibody: 6B4. Thrombosis and Haemostasis. 96(11). 671–684. 23 indexed citations

10.

Silence, Karen, Heidi Jonckheere, Peter Casteels, et al.. (2006). ALX-0081 Nanobody™, an Engineered Bivalent Anti-Thrombotic Drug Candidate with Improved Efficacy and Safety as Compared to the Marketed Drugs.. Blood. 108(11). 896–896. 2 indexed citations

11.

Jacquemin, Marc, Seb Lamprecht, Renaud Lavend’homme, et al.. (2005). The Determination of the Inhibitory Activity of Some Factor VIII Type II Inhibitor Antibodies Is Biased by the Type of Factor VIII Assay.. Blood. 106(11). 3200–3200. 2 indexed citations

12.

Cauwenberghs, Nancy, Muriel Meiring, S Vauterin, et al.. (2000). Antithrombotic Effect of Platelet Glycoprotein Ib–Blocking Monoclonal Antibody Fab Fragments in Nonhuman Primates. Arteriosclerosis Thrombosis and Vascular Biology. 20(5). 1347–1353. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact